Susan G. Komen evaluates and invests in science and technology to accelerate research discoveries in order to change the standard of breast cancer care and improve the delivery of that care. The organization is focused on conquering aggressive and metastatic breast cancers and eliminating breast cancer disparities with the goal of advancing personalized medicine and improving health outcomes for everyone.
The Susan G. Komen "ASPIRE: A Supplement to Promote Inclusion for Research Excellence" grant aims to enhance the diversity of the breast cancer research workforce. It provides established breast cancer scientists with supplemental funding to support research trainees from communities historically minoritized and marginalized in research. This initiative seeks to ensure a diverse group of highly trained scientists emerges as the next generation of leaders in breast cancer research and care, working towards health equity and better outcomes for all. The grant offers up to $100,000 per year to cover a trainee’s salary for one or two years.